Joe SimonsVerified account

@JoeSimonsFTC

Official account of Chairman Joe Simons. Twitter privacy policy governs here. Retweets, Follows and Likes ≠ Endorsements.

Joined May 2018

Tweets

You blocked @JoeSimonsFTC

Are you sure you want to view these Tweets? Viewing Tweets won't unblock @JoeSimonsFTC

  1. Retweeted
    Oct 1

    No, FTC Chairman is not emailing you. Scammers are sending emails pretending to be him though. If you get an email like this, remember it is NOT from the FTC. Report it at . More:

    Undo
  2. Sep 17

    Proud of for co-hosting 19th annual conference this week and maintaining a strong voice for US consumers and competitive markets on the global stage.

    Undo
  3. Sep 14

    Joined and AAG Delrahim today for panel on enforcement in the digital economy and ensuring competitive markets that serve consumers.

    Show this thread
    Undo
  4. Sep 14

    Honored to help launch the 's 19th annual conference today; info on the event at . My opening remarks:

    Show this thread
    Undo
  5. Retweeted
    Aug 5

    FTC testified today at an oversight hearing before about the agency’s work to protect consumers and promote competition, including its efforts to combat frauds designed to take advantage of consumers during the pandemic:

    Undo
  6. Jun 30

    We received useful comments from our Hearings and a public workshop hosted on March 11, 2020. Feedback has helped us make significant improvements to the Jan. draft. /4

    Show this thread
    Undo
  7. Jun 30

    Guidelines replace the framework for analyzing non-horizontal mergers contained in the DOJ’s 1984 Merger Guidelines /3

    Show this thread
    Undo
  8. Jun 30

    I join and in a statement: /2

    Show this thread
    Undo
  9. Jun 30

    Today, FTC and DOJ issued antitrust guidelines for evaluating vertical mergers. New Vertical Merger Guidelines provide transparency on analytical techniques, practices, and enforcement policies: /1

    Show this thread
    Undo
  10. Jun 4

    Today announced that HyperBeard is settling allegations it illegally collected kids’ data without parental consent. My statement:

    Undo
  11. May 12
    Undo
  12. May 5

    My colleagues may not like the result of the comprehensive and meticulous merger review process but the investigation simply did not uncover evidence suggesting harm would result from the merger based on these additional theories. /8

    Show this thread
    Undo
  13. May 5

    . and misrepresent that add’l theories of harm were not investigated with adequate rigor in this case: Chopra's statement: Slaughter's statement: /7

    Show this thread
    Undo
  14. May 5

    In reviewing proposed buyers, the Commission closely examines the buyer’s sources of financing, contingency planning, and ability to conduct adequate due diligence, among other factors. /6

    Show this thread
    Undo
  15. May 5

    Findings from the pharmaceutical portion of the 2017 Merger Remedies Study support the consent in this case. The study found that buyers that acquired on-market pharmaceutical products that were contract manufactured, cont’d to sell those products. /5

    Show this thread
    Undo
  16. May 5

    Our majority statement attempts to set the record straight, providing perspective, context, logic, and facts missing from ’s dissent: /4

    Show this thread
    Undo
  17. May 5

    Our colleagues & , who have in the past expressed and today reiterate their general opposition to pharmaceutical mergers, have come to a different conclusion about the proposed settlement and have voted against accepting it. /3

    Show this thread
    Undo
  18. May 5

    The Commission voted [3-2] to issue a complaint + accept a settlement resolving every substantial threat to competition uncovered by FTC staff + supported by the evidence, after a thorough investigation lasting 10 mos involving 40+ interviews and review of more than 430K docs. /2

    Show this thread
    Undo
  19. May 5

    Today announced that pharmaceutical companies AbbVie Inc. and Allergan plc have agreed to divest assets to settle charges that AbbVie’s proposed $63 billion acquisition of Allergan would violate federal law /1

    Show this thread
    Undo
  20. Apr 24

    I also want to commend FTC staff for their exhaustive investigation and work towards this victory. /6

    Show this thread
    Undo

Loading seems to be taking a while.

Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.

    You may also like

    ·